Arkolith/Insider Trading/APGE/Form 4

Dambkowski Carl

Chief Medical OfficerApogee Therapeutics, Inc. (APGE) · full profile →Form 4 · filed Apr 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$467K
Net Open-Market Flow
-$467K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 1, 2026Option exercise(M)4K$22.86$94K214K
Apr 1, 2026Sell(S)3K$84.31$227K211K
Apr 1, 2026Sell(S)3K$85.33$231K208K
Apr 1, 2026Sell(S)100$85.89$9K208K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2026Option exercise(M)4K—$0127K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-039709) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML